The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Effect of Statins on Skeletal Muscle Function
Open accessAbstract
Background—: Many clinicians believe that statins cause muscle pain, but this has not been observed in clinical trials, and the effect of statins on muscle performance has not been carefully studied. Methods and Results—: The Effect of Statins on Skeletal Muscle Function and Performance (STOMP) study assessed symptoms and measured creatine kinase, exercise capacity, and muscle strength before and after atorvastatin 80 mg or placebo was administered for 6 months to 420 healthy, statin-naive subjects. No individual creatine kinase value exceeded 10 times normal, but average creatine kinase increased 20.8±141.1 U/L ( P <0.0001) with atorvastatin. There were no significant changes in several measures of muscle strength or exercise capacity with atorvastatin, but more atorvastatin than placebo subjects developed myalgia (19 versus 10; P =0.05). Myalgic subjects on atorvastatin or placebo had decreased muscle strength in 5 of 14 and 4 of 14 variables, respectively ( P =0.69). Conclusions—: These results indicate that high-dose atorvastatin for 6 months does not decrease average muscle strength or exercise performance in healthy, previously untreated subjects. Nevertheless, this blinded, controlled trial confirms the undocumented impression that statins increase muscle complaints. Atorvastatin also increased average creatine kinase, suggesting that statins produce mild muscle injury even among asymptomatic subjects. This increase in creatine kinase should prompt studies examining the effects of more prolonged, high-dose statin treatment on muscular performance. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00609063.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the 420 statin-naïve subjects randomized to atorvastatin 80 mg daily or placebo for 6 months, 9.4% of the statin-treated and 4.6% of control subjects met the study definition of myalgia (P = 0.054)”
In the citing paper
“The STOMP study also found no differences in the measures of muscle strength or exercise performance between statin-treated and placebo subjects.”
In the citing paper
“The Effects of Statins on Muscle Performance (STOMP) study is, to our knowledge, the only randomized, double-blind, placebo-controlled study specifically designed to examine the effect of statins on skeletal muscle symptoms and performance.22”
In the citing paper
“suggesting that the incidence of muscle complaints due to the statin is considerably less than that reported in observational trials.”
In the citing paper
“Discomfort and weakness typically occur early (within 4–6 weeks after starting statin therapy22), but may still occur after many years of treatment.”
In the citing paper
“One study, designed specifically to study the effects of statins on muscle symptoms, suggests that the frequency of muscle-related complaints is ≏ 5%. 217”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [217]
In the citing paper
“Medications such as statins may provoke symptoms such as muscle pain or weakness, which can be confused with normal post-exercise soreness, especially in individuals not accustomed to PRT [[588], [589], [590]].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [588]
In the citing paper
“Medications such as statins may provoke symptoms such as muscle pain or weakness, which can be confused with normal post-exercise soreness, especially in individuals not accustomed to PRT [[588], [589], [590]].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [588]
In the citing paper
“One study, designed specifically to study the effects of statins on muscle symptoms, suggests that the frequency of muscle-related complaints is ~5%.217”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [217]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Arky, R. A. (1994) · Cited by 2,632
Thompson, P. D., Clarkson, P., & Karas, R. H. (2003) · JAMA · doi:10.1001/jama.289.13.1681 · Cited by 1,463
Self-citationBruckert, E., Hayem, G., Dejager, S., Yau, C., & Bégaud, B. (2005) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-005-5686-z · Cited by 1,226
ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins
Writing Committee Members:, Pasternak, R. C., Smith, S. C., Bairey-Merz, C. N., Grundy, S. M., Cleeman, J. I., & Lenfant, C. (2002) · Circulation · doi:10.1161/01.cir.0000032466.44170.44 · Cited by 1,088
Cerivastatin and Reports of Fatal Rhabdomyolysis
Staffa, J. A., Chang, J. T., & Green, L. (2002) · New England Journal of Medicine · doi:10.1056/nejm200202143460721 · Cited by 627
Statin-associated myopathy with normal creatine kinase levels
Phillips, P. S., Haas, R. H., Bannykh, S., Hathaway, S., Gray, N. L., Kimura, B. J., Vladutiu, G. D., England, J. D. F., & and the Scripps Mercy Clinical Research Center* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00009 · Cited by 565
Pasternak, R. C., Smith, S. C., Merz, C. N. B., Grundy, S. M., Cleeman, J. I., & Lenfant, C. J. M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02030-2 · Cited by 507
The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity
Hanai, J., Cao, P., Tanksale, P., Imamura, S., Koshimizu, E., Zhao, J., Kishi, S., Yamashita, M., Phillips, P. S., Sukhatme, V. P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32741 · Cited by 281
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 501
Pergolizzi, J. V., Coluzzi, F., Colucci, R. D., Olsson, H., LeQuang, J. A., Al‐Saadi, J., & Magnusson, P. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1734451 · Cited by 47
Bonfim, M. R., Oliveira, A. S. B., Amaral, S. L., & Monteiro, H. L. (2015) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20150005 · Cited by 43
Influence of statins on distinct circulating microRNAs during prolonged aerobic exercise
Min, P., Park, J., Isaacs, S. K., Taylor, B. A., Thompson, P. D., Troyanos, C., d’Hemecourt, P. A., Dyer, S., Chan, S. Y., & Baggish, A. L. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00654.2015 · Cited by 44
Self-citationThe effects of statins on exercise and physical activity
Noyes, A. M., & Thompson, P. D. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.07.003 · Cited by 44
Self-citationKorhonen, M. J., Pentti, J., Hartikainen, J. E. K., Ilomäki, J., Setoguchi, S., Liew, D., Mika Kivimaki, B., & Vahtera, J. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014168 · Cited by 44
Ballard, K. D., Parker, B. A., Capizzi, J. A., Grimaldi, A. S., Clarkson, P. M., Cole, S. M., Keadle, J., Chipkin, S. R., Pescatello, L. S., Simpson, K., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.001 · Cited by 42
Self-citationDohlmann, T. L., Morville, T. H., Kuhlman, A. B., Chrøis, K. M., Helge, J. W., Dela, F., & Larsen, S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01185 · Cited by 44
Gunta, S. P., O’Keefe, J. H., O’Keefe, E. L., & Lavie, C. J. (2023) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2023.02.007 · Cited by 44
Statin tolerability: In defence of placebo-controlled trials
Tobert, J. A., & Newman, C. B. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315602861 · Cited by 43
Banach, M., & Mikhailidis, D. P. (2018) · Cardiology Clinics · doi:10.1016/j.ccl.2017.12.004 · Cited by 42
Muscle biopsy: what and why and when?
Walters, R. J. L., & Baborie, A. (2020) · Practical Neurology · doi:10.1136/practneurol-2019-002465 · Cited by 42
Hilton‐Jones, D. (2018) · Practical Neurology · doi:10.1136/practneurol-2017-001738 · Cited by 41
Keen, H. I., Krishnarajah, J., Bates, T. R., & Watts, G. F. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.937422 · Cited by 40
Muscle and statins: from toxicity to the nocebo effect
Pedro‐Botet, J., Climent, E., & Benaiges, D. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1615053 · Cited by 40
Genetic and immunologic susceptibility to statin-related myopathy
Patel, J., Superko, H. R., Martin, S. S., Blumenthal, R. S., & Christopher‐Stine, L. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.03.025 · Cited by 38
Southern, W. M., Nichenko, A. S., Shill, D. D., Spencer, C. C., Jenkins, N. T., McCully, K. K., & Call, J. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172551 · Cited by 39
Statin-associated muscle symptoms: position paper from the Luso-Latin American Consortium
Sposito, A. C., Faria‐Neto, J. R., de Carvalho, L. S. F., Lorenzatti, A. J., Cafferata, A., Elikir, G. D., Esteban, E., Villegas, E. C. M., Bodanese, L. C., Rodrigo Alonso, K., et al. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1252740 · Cited by 38
Laufs, U., Scharnagl, H., & März, W. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000236 · Cited by 39
Sharma, S., Mahanty, M., Rahaman, S. G., Mukherjee, P., Dutta, B., Khan, M. I., Sankaran, K. R., He, X., Kesavalu, L. N., Li, W., et al. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18177 · Cited by 34
Statin Intolerance: Diagnosis and Remedies
Pirillo, A., & Catapano, A. L. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0582-z · Cited by 35
Deichmann, R. E., Lavie, C. J., Asher, T., DiNicolantonio, J. J., O’Keefe, J. H., & Thompson, P. D. (2015) · Europe PMC (PubMed Central) · Cited by 35
Self-citationThe Benefits and Risks of Statin Therapy in Ischemic Stroke: A Review of the Literature
Zhao, S., Wang, Z., & Xiao, Z.-J. (2019) · Neurology India · doi:10.4103/0028-3886.266274 · Cited by 35
Abed, W., Abujbara, M. A., Batieha, A. M., & Ajlouni, K. M. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103304 · Cited by 37
Wang, Y., Pan, Y., Hou, M., Luo, R., He, J., Lin, F., Xia, X., Li, P., He, C., He, P., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115736 · Cited by 34
Prosarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure
Bielecka-Dabrowa, A. M., Fabiś, J., Mikhailidis, D. P., von Haehling, S., Sahebkar, A., Rysz, J., & Banach, M. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.003 · Cited by 30
Coenzyme Q10 as Treatment for Statin-Associated Muscle Symptoms—A Good Idea, but…
Zaleski, A. L., Taylor, B. A., & Thompson, P. D. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy010 · Cited by 32
Self-citationProbiotics Bring New Hope for Atherosclerosis Prevention and Treatment
Zhai, T., Wang, P., Hu, X., & Zheng, L. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3900835 · Cited by 34
The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy
Chung, H. R., Vakil, M., Munroe, M., Parikh, A., Meador, B. M., Wu, P. T., Jeong, J., Woods, J. A., Wilund, K. R., & Boppart, M. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168065 · Cited by 33
The association between fat-to-muscle ratio and metabolic disorders in type 2 diabetes
Liu, D., Zhong, J., Ruan, Y., Zhang, Z., Sun, J. M., & Chen, H. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00748-y · Cited by 34
The Effects of Statin Medications on Aerobic Exercise Capacity and Training Adaptations
Murlasits, Z., & Radak, Z. O. (2014) · Sports Medicine · doi:10.1007/s40279-014-0224-4 · Cited by 32
Anti-HMGCR myopathy: clinical and histopathological features, and prognosis
Kurashige, T. (2021) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000832 · Cited by 31
Clinical profile of statin intolerance in the phase 3 GAUSS-2 Study
Cho, L., Rocco, M., Colquhoun, D., Sullivan, D., Rosenson, R. S., Dent, R., Xue, A., Scott, R., Wasserman, S. M., & Stroes, E. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6655-4 · Cited by 30
Practical aspects in the management of statin-associated muscle symptoms (SAMS)
Laufs, U., Filipiak, K., Gouni‐Berthold, I., Catapano, A. L., Mandraffino, G., & Benlian, P. (2017) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(17)30024-7 · Cited by 30
Statin Intolerance Clinical Guide 2018
Kajinami, K., Tsukamoto, K., Koba, S., Inoue, I., Yamakawa, M., Suzuki, S., Hamano, T., Saito, H., Saito, Y., Masuda, S., et al. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.50948 · Cited by 32
Panza, G. A., Taylor, B. A., Dada, M. R., & Thompson, P. D. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.01.004 · Cited by 30
Self-citationStatin associated muscle symptoms: An update and review
Dicken, W., Mehta, A., Karagiannis, A. D., Jain, V., Vavuranakis, M., Sperling, L. S., & Cassimatis, D. C. (2022) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2022.11.010 · Cited by 30
Statin use and safety concerns: an overview of the past, present, and the future
Mulchandani, R., Lyngdoh, T., & Kakkar, A. K. (2020) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1796966 · Cited by 29
Initial statin dose after myocardial infarction and long-term cardiovascular outcomes
Kytö, V., Rautava, P. T., & Tornio, A. (2022) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvac064 · Cited by 28
Li, C., Liu, H., Yang, L., Liu, R., Yin, G., & Xie, Q. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103286 · Cited by 27
Manini, T. M., Anton, S. D., Beavers, D. P., Cauley, J. A., Espeland, M. A., Fielding, R. A., Kritchevsky, S. B., Leeuwenburgh, C., Lewis, K. H., Liu, C. K., et al. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14965 · Cited by 28
Kristiansen, O., Vethe, N. T., Peersen, K., Wang Fagerland, M., Sverre, E., Prunés Jensen, E., Lindberg, M., Gjertsen, E., Gullestad, L., Perk, J., et al. (2021) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa076 · Cited by 27
RYAN, T. E., Torres, M. J., Lin, C., Clark, A. H., Brophy, P. M., Smith, C. A., Smith, C. D., Morris, E. M., Thyfault, J. P., & Neufer, P. D. (2024) · JCI Insight · doi:10.1172/jci.insight.174125 · Cited by 27
Williams, P. T., & Thompson, P. D. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.06.019 · Cited by 26
Self-citationLipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease
Belch, J. J. F., Brodmann, M., Baumgärtner, I., Binder, C. J., Casula, M., Heiß, C., Kahan, T., Parini, P., Poredoš, P., Catapano, A. L., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.09.022 · Cited by 27
2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance
Chien, S.-C., Chen, P.-S., Huang, Y., Tang, S., Li, Y.-H., & Yeh, H. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.11.017 · Cited by 26
Cardiovascular Risk Factors and Disease in Women
Gill, S. K. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2015.01.007 · Cited by 25
Addressing Statin Adverse Effects in the Clinic
Katz, D. H., Intwala, S., & Stone, N. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414529622 · Cited by 27
Statin therapy in patients with cirrhosis
Wright, A. P., Adusumalli, S., & Corey, K. E. (2014) · Frontline Gastroenterology · doi:10.1136/flgastro-2014-100500 · Cited by 25
The Future of Clinical Trial Design: The Transition from Hard Endpoints to Value-Based Endpoints
Kruizinga, M. D., Stuurman, F. E., Groeneveld, G. J., & Cohen, A. F. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_302 · Cited by 26
Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease
Belch, J. J. F., Brodmann, M., Baumgärtner, I., Binder, C. J., Casula, M., Heiß, C., Kahan, T., Parini, P., Poredoš, P., Catapano, A. L., et al. (2021) · VASA · doi:10.1024/0301-1526/a000969 · Cited by 26
Medical Management of Dyslipidemia for Secondary Stroke Prevention: Narrative Review
Chang, Y., Eom, S., Kim, M.-J., & Song, T. (2023) · Medicina · doi:10.3390/medicina59040776 · Cited by 25
Izquierdo, M., Ramírez‐Vélez, R., & Singh, M. F. (2025) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2025.100763 · Cited by 29
Algorithms to Identify Statin Intolerance in Medicare Administrative Claim Data
Colantonio, L. D., Kent, S. T., Huang, L., Chen, L., Monda, K. L., Șerban, M.-C., Manthripragada, A. D., Kilgore, M. L., Rosenson, R. S., & Muntner, P. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6680-3 · Cited by 24
Current pharmacotherapeutic options for primary dyslipidemia in adults
Cicero, A. F. G., Landolfo, M., Ventura, F., & Borghi, C. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1604687 · Cited by 24
SAMSON and the Nocebo Effect: Management of Statin Intolerance
Krishnamurthy, A., Bradley, C., Ascunce, R. R., & Kim, S. M. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01729-x · Cited by 25
Quek, R. G. W., Fox, K. M., Wang, L., Li, L., Gandra, S. R., & Wong, N. D. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.11.035 · Cited by 24
Pedro‐Botet, J., Núñez-Cortés, J. M., Chillarón, J. J., Roux, J. A. F., & Rius, J. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1238068 · Cited by 24
What to Believe and Do About Statin-Associated Adverse Effects
Thompson, P. D. (2016) · JAMA · doi:10.1001/jama.2016.16557 · Cited by 24
Self-citationMa, X., Zhang, X., Awad, J. M., Xie, G., Qiu, W., Muriph, R. E., & Zhang, W. (2019) · Tetrahedron Letters · doi:10.1016/j.tetlet.2019.151392 · Cited by 24
Jacobson, T. A., Khan, M. A. S., Maki, K. C., Brinton, E. A., & Cohen, J. D. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.09.006 · Cited by 23
Turner, R. M., Yin, P., Hanson, A., FitzGerald, R., Morris, A. P., Stables, R., Jorgensen, A., & Pirmohamed, M. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.12.007 · Cited by 24
Statins, Exercise, and Exercise Training
Thompson, P. D., & Parker, B. A. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.030 · Cited by 23
Self-citationTaylor, B. A. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0251-2 · Cited by 22
Shah, M., Shrestha, K., Tseng, C., Goyal, A., Liewluck, T., & Gupta, L. (2024) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.15337 · Cited by 25
Exercise-induced Myalgia may Limit the Cardiovascular Benefits of Statins
Opie, L. H. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-013-6483-8 · Cited by 21
Hung, R. K., Al-Mallah, M. H., Qadi, M. A., Shaya, G. E., Blumenthal, R. S., Nasir, K., Brawner, C. A., Keteyian, S. J., & Blaha, M. J. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.04.030 · Cited by 21
Henderson, R. M., Lovato, L., Miller, M. E., Fielding, R. A., Church, T., Newman, A. B., Buford, T. W., Pahor, M., McDermott, M. M., Stafford, R. S., et al. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw057 · Cited by 21
Albuquerque, E. L., Fulco, U. L., Caetano, E. W. S., & Freire, V. N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108774956.011 · Cited by 21
Skeletal muscle ultrastructure and function in statin-tolerant individuals
Rengo, J. L., Callahan, D. M., Savage, P. D., Ades, P. A., & Toth, M. J. (2015) · Muscle & Nerve · doi:10.1002/mus.24722 · Cited by 21
Effect of atorvastatin on testosterone levels
Shawish, M. I., Bagheri, B., Musini, V. M., Adams, S. P., & Wright, J. M. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013211.pub2 · Cited by 22
Statin use, development of sarcopenia, and long-term survival after endovascular aortic repair
Lindström, I., Protto, S., Khan, N., Väärämäki, S., Oksala, N., & Hernesniemi, J. A. (2021) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2021.04.054 · Cited by 21
Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2, and CYP2C9 variants
Lönnberg, K. I., Tornio, A., Hirvensalo, P., Keskitalo, J. E., Mustaniemi, A.-L., Kiiski, J. I., Filppula, A. M., & Niemi, M. (2023) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000504 · Cited by 22
Statin-associated muscle symptoms EAS Consensus Panel paper focuses on this neglected patient group
Stock, J. K. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.049 · Cited by 21
The effect of statins on RyR and RyR-associated disease
Haseeb, M., & Thompson, P. D. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01003.2020 · Cited by 20
Self-citationHigh-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better
Grundy, S. M., Stone, N. J., Blumenthal, R. S., Braun, L. T., Heidenreich, P. A., Lloyd-Jones, D., Orringer, C. E., Saseen, J. J., Smith, S. C., Sperling, L. S., et al. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.02.032 · Cited by 20
Therapeutic Response of miR-145 Micelles on Patient-Derived Vascular Smooth Muscle Cells
Patel, N., Chin, D. D., Magee, G. A., & Chung, E. J. (2022) · Frontiers in Digital Health · doi:10.3389/fdgth.2022.836579 · Cited by 20
Golder, S., Weissenbacher, D., O’Connor, K., Hennessy, S., Gross, R., & Gonzalez‐Hernandez, G. (2022) · Drug Safety · doi:10.1007/s40264-022-01212-0 · Cited by 20
Erlandson, K. M., Jiang, Y., Debanne, S. M., & McComsey, G. A. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0191 · Cited by 20
Fernandes, V., Santos, M. J., & Pérez, A. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2016.01.001 · Cited by 20
Taylor, B. A., Lorson, L., White, C. M., & Thompson, P. D. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.11.011 · Cited by 20
Self-citationAcute Coronary Syndrome in Idiopathic Inflammatory Myopathies: A Population-based Study
Leclair, V., Svensson, J., Lundberg, I. E., & Holmqvist, M. E. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.181248 · Cited by 20
To study the effect of high dose Atorvastatin 40 mg versus 80 mg in patients with dyslipidemia
Agrawal, D. K., Manchanda, S. C., Sawhney, J. P. S., Kandpal, B., Jain, R., Mehta, A., Mohanty, A. K., Passey, R., Makhija, A., & Sharma, M. K. (2018) · Indian Heart Journal · doi:10.1016/j.ihj.2018.01.034 · Cited by 18
Kariyanna, P. T., Haseeb, S. O., Chowdhury, Y. S., Jayarangaiah, A., Maryniak, A., Mo, G., Hegde, S., Marmur, J. D., & McFarlane, I. M. (2019) · American Journal of Medical Case Reports · doi:10.12691/ajmcr-7-12-9 · Cited by 20
Habte, M. L., Seifu, D., Degef, M., Menon, M. K., Yifter, H., & Feyisa, T. O. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s234382 · Cited by 19
Baptista, L. C. P., Veríssimo, M. T., & Martins, R. A. (2018) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13284 · Cited by 18
Naing, C. M., & Ni, H. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013268.pub2 · Cited by 17
Impact of Statins on Physical Activity and Fitness: Ally or Adversary?
Franklin, B. A., & Lavie, C. J. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.08.014 · Cited by 18
Increased creatine kinase with statin treatment may identify statin-associated muscle symptoms
Taylor, B. A., Panza, G. A., & Thompson, P. D. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.028 · Cited by 18
Self-citationNogueira, A., Strunz, C. M. C., Takada, J. Y., & Mansur, A. D. P. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0379 · Cited by 18
Schweitzer, A. M., Gingrich, M. A., Hawke, T. J., & Rebalka, I. A. (2020) · European Journal of Applied Physiology · doi:10.1007/s00421-020-04360-2 · Cited by 22
Association between Statin Use and Balance in Older Adults
Langeard, A., Saillant, K., Cloutier, E. C., Gayda, M., Lesage, F., Nigam, A., Bherer, L., & Fraser, S. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17134662 · Cited by 18
Macchi, C., Bonalume, V., Greco, M. F., Mozzo, M., Melfi, V., Sirtori, C. R., Magnaghi, V., Corsini, A., & Ruscica, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105415 · Cited by 18
Statin intolerance in a referral lipid clinic
Lakey, W. C., Greyshock, N. G., Kelley, C. E., Siddiqui, M. A., Ahmad, U., Lokhnygina, Y. V., & Guyton, J. R. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.03.004 · Cited by 18
Statin use and self-reported swimming performance in US masters swimmers
Terpak, K., Guthrie, S. K., & Erickson, S. R. (2014) · Journal of Sports Sciences · doi:10.1080/02640414.2014.942688 · Cited by 17
Sivkov, A., Павловна, Ч. Н., Горенков, Р. В., Sivkov, S., Sivkova, S., & Savina, T. S. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01586-7 · Cited by 17
Frailty and polypharmacy in the community‐dwelling elderly with multiple chronic diseases
Chuang, Y. N., Chen, C. C., Wang, C. J., Chang, Y., & Liu, Y. H. (2023) · Psychogeriatrics · doi:10.1111/psyg.12936 · Cited by 17
Allard, N. A. E., Janssen, L., Lagerwaard, B., Nuijten, M. A. H., Bongers, C. C. W. G., Rodenburg, R. J., Thompson, P. D., Eijsvogels, T. M. H., Assendelft, W. J., Schirris, T. J. J., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.01.043 · Cited by 17
Self-citationPredictors of Suboptimal Gain in Exercise Capacity After Cardiac Rehabilitation
Bargehr, J., Thomas, C. S., Oken, K. R., Thomas, R. J., López-Jiménez, F. A., & Trejo-Gutiérrez, J. F. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.08.005 · Cited by 17
Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care
Wiggins, B. S., Backes, J. M., & Hilleman, D. (2022) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2681 · Cited by 17
Differential Diagnosis of HyperCKemia
Kley, R. A., Schmidt‐Wilcke, T., & Vorgerd, M. (2018) · Neurology International Open · doi:10.1055/s-0043-124361 · Cited by 17
Metadata
- Authors
- Parker, B. A., Capizzi, J. A., Grimaldi, A. S., Clarkson, P. M., Cole, S. M., Keadle, J., Chipkin, S., Pescatello, L. S., Simpson, K., White, C. M., & Thompson, P. D.
- Affiliations
- Hartford Hospital (US)
- Venue
- Circulation
- Published
- 2013-01
- Volume
- 127
- Issue
- 1
- Pages
- 96-103
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC4450764
- OpenAlex
- W1982914740
- Cited by
- 500
- References
- 27
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 30 · 2023: 25 · 2022: 43 · 2021: 39 · 2020: 37 · 2019: 39 · 2018: 42 · 2017: 41 · 2016: 57 · 2015: 52 · 2014: 33 · 2013: 17
- FWCI
- 33.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL081893)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- statins, atorvastatin, skeletal muscle function, muscle strength, exercise capacity, creatine kinase, myalgia, statin-induced myopathy, high-intensity statin therapy, healthy volunteers
- MeSH terms
- Atorvastatin, Adult, Creatine Kinase, Double-Blind Method, Exercise Test, Female, Heptanoic Acids, Humans, Male, Middle Aged, Placebos, Pyrroles, Exercise Tolerance, Muscle, Skeletal, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Muscle Strength, Young Adult, Musculoskeletal Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
